The Global Neuro rehabilitation device market is majorly driven by the global increase in the elderly population, growing prevalence of neurological diseases and technological advancements in the neurorehabilitation devices. Over the forecast period of 2018-2026, the market is slated to rise at a CAGR of 15.24%.
The Global Neuro rehabilitation device market is segmented on the basis of products, end users and applications. The products segment includes Brain-computer interface, Neuro-robotic systems, Non-invasive stimulators and Wearable device. The end-users for this market are Hospitals/clinics, Cognitive care centers, Research institutes and others. The application center of this market can be further classified into spinal cord injury, cerebral palsy, Parkinson’s disease, traumatic brain injury, and stroke.
The regional segmentation of the Global Neuro Rehabilitation Devices market has been done into Europe, Asia-Pacific, North America and rest of the world. The North American market is expected to dominate the region by the end of 2026. The region is witnessing increasing cases of Parkinson’s and Alzheimer’s disease in its general populace. On the other hand, the Asia-Pacific market is anticipated to show the fastest growth over the forecast period of 2018-2026, owing to its developing economy.
Major companies engaged in this market are Ectron Limited, Bioxtreme Robotics Rehabilitation, Ekso Bionics Holding Inc, Hocoma Ag, Helius Medical Technologies, Kinestica, Medtronic.Inc, Kinova Robotics, Neurostyle Pte Ltd, St. Jude Medical Inc. (Acquired by Abbott Laboratories).